Form D Explorer

Form D — ZETAGEN THERAPEUTICS, INC.

0001730728-25-000003 · filed 2025-11-12

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $12,999,998
Total sold: $12,908,022
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: ZETAGEN THERAPEUTICS, INC.
CIK: 1730728
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 841 EAST FAYETTE STREET
SYRACUSE, NY 13210
Phone: 315-475-2200

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Nikhil Thakur, MD · Executive Officer

Andover, MA Find on LinkedIn ↗
Peter B. Finn · Executive Officer

Boston, MA Find on LinkedIn ↗
Joe C Loy · Executive Officer

Weatherford, TX Find on LinkedIn ↗
Donald Brown · Director

Hopkinton, MA Find on LinkedIn ↗
Ashok Kaveeshwar · Director

Bethesda, MD Find on LinkedIn ↗
Richard Warburg · Director

Bethesda, MD Find on LinkedIn ↗

View original on SEC EDGAR.